Fatty liver: a novel component of the metabolic syndrome - PubMed (original) (raw)
Review
Fatty liver: a novel component of the metabolic syndrome
Anna Kotronen et al. Arterioscler Thromb Vasc Biol. 2008 Jan.
Abstract
Although the epidemic of obesity has been accompanied by an increase in the prevalence of the metabolic syndrome, not all obese develop the syndrome and even lean individuals can be insulin resistant. Both lean and obese insulin resistant individuals have an excess of fat in the liver which is not attributable to alcohol or other known causes of liver disease, a condition defined as nonalcoholic fatty liver disease (NAFLD) by gastroenterologists. The fatty liver is insulin resistant. Liver fat is highly significantly and linearly correlated with all components of the metabolic syndrome independent of obesity. Overproduction of glucose, VLDL, CRP, and coagulation factors by the fatty liver could contribute to the excess risk of cardiovascular disease associated with the metabolic syndrome and NAFLD. Both of the latter conditions also increase the risk of type 2 diabetes and advanced liver disease. The reason why some deposit fat in the liver whereas others do not is poorly understood. Individuals with a fatty liver are more likely to have excess intraabdominal fat and inflammatory changes in adipose tissue. Intervention studies have shown that liver fat can be decreased by weight loss, PPARgamma agonists, and insulin therapy.
Similar articles
- Fat in the liver and insulin resistance.
Yki-Järvinen H. Yki-Järvinen H. Ann Med. 2005;37(5):347-56. doi: 10.1080/07853890510037383. Ann Med. 2005. PMID: 16179270 Review. - Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H. Yki-Järvinen H. Dig Dis. 2010;28(1):203-9. doi: 10.1159/000282087. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460912 Review. - Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
Fan JG. Fan JG. J Dig Dis. 2008 May;9(2):63-7. doi: 10.1111/j.1751-2980.2008.00323.x. J Dig Dis. 2008. PMID: 18419637 Review. - Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Marchesini G, et al. Hepatology. 2003 Apr;37(4):917-23. doi: 10.1053/jhep.2003.50161. Hepatology. 2003. PMID: 12668987 - Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
Rafiq N, Younossi ZM. Rafiq N, et al. Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):207-15. doi: 10.1586/17474124.2.2.207. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072356 Review.
Cited by
- Prevalence of Pancreatic Steatosis and Its Associated Factors in Turkey: A Nation-Wide Multicenter Study.
Sezgin O, Yaraş S, Cindoruk M, Kasap E, Ünal H, Köksal AŞ, Yıldırım AE, Özşeker B, Oruç N, Soytürk M, Kaçar S, Kaya M, Irak K, Gökden Y, Koç DÖ, Özdoğan O, Altıntaş E, Ekmen N, Saruç M, Acar Ş, Polat M, Barutçu S, Bengi G, Gökbulut V, Ünal NG, Oğuz D. Sezgin O, et al. Turk J Gastroenterol. 2024 Mar;35(3):239-254. doi: 10.5152/tjg.2024.23583. Turk J Gastroenterol. 2024. PMID: 39128120 Free PMC article. - Associations of four surrogate insulin resistance indexes with non-alcoholic steatohepatitis in Chinese patients with obesity: a cross-sectional study.
Xiao J, Zhang X, Chang L, Yu H, Sun L, Zhu C, He Q. Xiao J, et al. Endocrine. 2024 May 30. doi: 10.1007/s12020-024-03888-z. Online ahead of print. Endocrine. 2024. PMID: 38814373 - Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol.
de Girolamo G, Andreassen OA, Bauer M, Brambilla P, Calza S, Citerà N, Corcoy R, Fagiolini A, Garcia-Argibay M, Godin O, Klingler F, Kobayashi NF, Larsson H, Leboyer M, Matura S, Martinelli A, De la Peña-Arteaga V, Poli R, Reif A, Ritter P, Rødevand LN, Magno M, Caselani E; BIPCOM consortium. de Girolamo G, et al. Int J Bipolar Disord. 2024 May 4;12(1):15. doi: 10.1186/s40345-024-00337-8. Int J Bipolar Disord. 2024. PMID: 38703295 Free PMC article. - Effects of fat sources on liver characteristics and intestinal morphometry in an early-life animal model.
Gutiérrez Zorrilla IM, Bernuy-Osorio ND, Zea Mendoza O, Yabar Villanueva EF, Vílchez-Perales C. Gutiérrez Zorrilla IM, et al. Rev Peru Med Exp Salud Publica. 2023 Out-Dec;40(4):459-465. doi: 10.17843/rpmesp.2023.404.12804. Rev Peru Med Exp Salud Publica. 2023. PMID: 38597474 Free PMC article. - Associations of ALT/AST, a marker of hepatosteatosis, with pulse rate in young women and with blood pressure in middle-aged women independently of abdominal fat accumulation and insulin resistance.
Minato-Inokawa S, Tsuboi-Kaji A, Honda M, Takeuchi M, Kitaoka K, Kurata M, Wu B, Kazumi T, Fukuo K. Minato-Inokawa S, et al. Diabetol Int. 2024 Jan 24;15(2):270-277. doi: 10.1007/s13340-023-00689-z. eCollection 2024 Apr. Diabetol Int. 2024. PMID: 38524930
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous